ARCHIVES

Intense Therapies Better Than Lower Dose For AML

This article is from The Cancer Letter archive.

Vol. 27 No. 11 | November 26, 2004

Download PDF Visit The Full Archive

Related Articles

Informatics: Gore Helps NCI Open CGAP Website

August 8, 1997

Sandra Swain Elected ASCO President for 2012

December 10, 2010

Lilly drug Alimta misses the target, but wins ODAC endorsement for lung cancer. FDA’s Pazdur tells ODAC that decision on Alimta requires clinical judgment.

July 30, 2004

St. Jude Offers Three Fellowships

May 3, 1985

Markup Of Cancer Act Renewal Set For Mid-October

September 21, 1979

In Brief: William Peters To Leave Duke To Head Michigan Cancer Foundation, Prentis Center

April 7, 1995